The Infona portal uses cookies, i.e. strings of text saved by a browser on the user's device. The portal can access those files and use them to remember the user's data, such as their chosen settings (screen view, interface language, etc.), or their login data. By using the Infona portal the user accepts automatic saving and using this information for portal operation purposes. More information on the subject can be found in the Privacy Policy and Terms of Service. By closing this window the user confirms that they have read the information on cookie usage, and they accept the privacy policy and the way cookies are used by the portal. You can change the cookie settings in your browser.
Under the irradiation of a 915 nm laser, MEO2MA@MEO2MA‐co‐OEGMA‐CuS‐DOX (G‐CuS‐DOX) nanocapsules increase the temperature of tumors (T). As described by Z. G. Chen, H. P. Wang, M. F. Zhu, and co‐workers on page 245, when T exceeds 42 °C, synergic photothermal‐/chemotherapy can be controllably switched on, resulting in efficient destruction of cancer cells in vivo.
In vivo MEO2MA@MEO2MA‐co‐OEGMA‐CuS‐DOX (G‐CuS‐DOX) nanocapsules increase the temperature of tumors from room temperature to 57 °C due to the photothermal effect under irradiation from a 915‐nm laser. When the temperature exceeds 42 °C, photothermal therapy of G‐CuS‐DOX is switched on. Simultaneously, higher temperatures (>LCST, 42 °C) induce volume shrinkage of G‐CuS‐DOX in vivo, leading to the...
Set the date range to filter the displayed results. You can set a starting date, ending date or both. You can enter the dates manually or choose them from the calendar.